Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Tamar Fisher"'
Autor:
Brian P. Bernstein, MBBCh, FCS(SA)Orth, Mlekeleli T.N. Duma, MBBCh, FCS(SA)Orth, Omer Or, MD, Tamar Fisher-Negev, Pharm-D, Yoram Weil, MD
Publikováno v:
OTA International, Vol 5, Iss 3S, p e171 (2022)
Abstract. Osteoporosis is a common disease of the elderly. Many patients at high risk are neither identified nor treated. A Fracture Liaison Service is a coordinated model of care for secondary fracture prevention. Several national quality indicators
Externí odkaz:
https://doaj.org/article/c7bf11a5423d45ca84e626b27de7ed02
Autor:
Amichai Perlman, Ehud Horwitz, Bruria Hirsh-Raccah, Gefen Aldouby-Bier, Tamar Fisher Negev, Sarit Hochberg-Klein, Yosef Kalish, Mordechai Muszkat
Publikováno v:
Israel Journal of Health Policy Research, Vol 8, Iss 1, Pp 1-9 (2019)
Abstract Introduction In the past decade, direct-acting oral anticoagulants (DOAC) have been introduced to medical practice for several indications, with a wide range of dosing regimens. As both over- and under-dosing might lead to life-threatening e
Externí odkaz:
https://doaj.org/article/0ccf37aade114284b9ab8328a92b297b
Autor:
Hana Golan, Raphael Mechoulam, Reem Smoum, Efrat Cohen-Zada, Sara Pri-Chen, Sapir Wiener, Igor Grinberg, Dekel D. Bar-Lev, Christeeneh G. Haj, Tamar Fisher, Amos Toren
Publikováno v:
Biomedicines, Vol 10, Iss 7, p 1552 (2022)
Modulation of the endogenous cannabinoid system has been suggested as a potential anticancer strategy. In the search for novel and less toxic therapeutic options, structural modifications of the endocannabinoid anandamide and the synthetic derivative
Externí odkaz:
https://doaj.org/article/556658323e5743f49af9e073437525f0
Autor:
Omer, Or, Tamar, Fisher Negev, Vered, Hadad, Ran, Shabtai, Alona, Katzir, Yotam, Wei, Meir, Liebergall
Publikováno v:
The Israel Medical Association journal : IMAJ. 23(8)
Osteoporosis is a common medical condition in older ages. A devastating result of osteoporosis may be a hip fracture with up to 30% mortality rate in one year. The compliance rate of osteoporotic medication following a hip fracture is 20% in the west
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Dvora Nass, Tamar Rubinek, Elad Jacoby, Tamar Fisher, Naama Peshes-Yeloz, Ido Wolf, Anton Wohl, Lior Ungar, Moshe Leitner, Zvi R. Cohen
Publikováno v:
World Neurosurgery. 130:e324-e332
Klotho, a single-pass transmembrane protein associated with premature aging, acts as a tumor suppressor gene by inhibiting insulin/insulin-like growth factor-1 and fibroblast growth factor pathways. Downregulated Klotho expression is reported in mela
Autor:
Yosef Kalish, Tamar Fisher Negev, Bruria Hirsh-Raccah, Amichai Perlman, Ilan Matok, Gil Dagan, Sarit Hochberg-Klein, Lotan Choshen Cohen, Laurent Azoulay, Ehud Horwitz, Mordechai Muszkat, Gefen Aldouby-Bier
Publikováno v:
Journal of Thrombosis and Thrombolysis. 47:590-595
Little is known regarding the management of direct oral anticoagulants (DOACs) in patients with enzyme-inducing drugs (EID). The use of EID may lead to sub-therapeutic concentrations of DOACs and to treatment failure. Thus, many patients on EIDs cann
Autor:
Nitzan Cal, Gal Goldstein, Tamar Fisher, Ruty Mehrian-Shai, Ortal Barel, Moshe Leitner, Victoria Marcu, Bella Bielorai, Michal Yalon, Amos Toren, Hana Golan, Ginette Schiby, Luba Trakhtenbrot
Publikováno v:
Acta Haematologica. 141:119-127
Background: The WHO defined myeloid and lymphoid neoplasms (MLN) with eosinophilia associated with PDGFRB, PDGFRA, FGFR1 rearrangements as a new entity in 2016. PDGFRB-rearranged MLN sensitive to imatinib were described in adult patients. We report t
Autor:
Yosef Kalish, Bruria Hirsh-Raccah, Gefen Aldouby-Bier, Tamar Fisher Negev, Mordechai Muszkat, Ehud Horwitz, Amichai Perlman, Sarit Hochberg-Klein
Publikováno v:
Israel Journal of Health Policy Research
Israel Journal of Health Policy Research, Vol 8, Iss 1, Pp 1-9 (2019)
Israel Journal of Health Policy Research, Vol 8, Iss 1, Pp 1-9 (2019)
Introduction In the past decade, direct-acting oral anticoagulants (DOAC) have been introduced to medical practice for several indications, with a wide range of dosing regimens. As both over- and under-dosing might lead to life-threatening events, de
Autor:
Amos Toren, Tatyana Pismenyuk, Michal Yalon, Shani Freedman, Amos J. Simon, Tamar Fisher, Itai Moshe, Juergen K.V. Reichardt, Shlomi Constantini, Yael Mardor, David Last, David Guez, Dianne Daniels, Moria Assoulin, Ruty Mehrian-Shai
Publikováno v:
Oncotarget
// Amos Toren 1 , Tatyana Pismenyuk 1 , Michal Yalon 1 , Shani Freedman 1 , Amos J. Simon 1 , Tamar Fisher 1 , Itai Moshe 1 , Juergen K.V. Reichardt 2 , Shlomi Constantini 3 , Yael Mardor 4 , David Last 4 , David Guez 4 , Dianne Daniels 4 , Moria Ass